Started as a battery company in the 1990s in Shenzhen, BYD is now one of the best-selling EV brands in the world. Once mocked by Elon Musk, the company’s startling growth made it a global player and has sparked tariffs in the US and EU.

On today’s Big Take Asia Podcast, host K. Oanh Ha talks to Bloomberg’s Gabrielle Coppola and Danny Lee about the company’s aggressive expansion and what it means for the global auto market.

Read more: BYD Is Winning the Global Race to Make Cheaper EVs

Started as a battery company in the 1990s in Shenzhen, BYD is now one of the best-selling EV brands in the world. Once mocked by Elon Musk, the company’s startling growth made it a global player and has sparked tariffs in the US and EU.
On today’s Big Take Asia Podcast, host K. Oanh Ha talks to Bloomberg’s Gabrielle Coppola and Danny Lee about the company’s aggressive expansion and what it means for the global auto market.
Read more: <a href="https://www.bloomberg.com/news/features/2024-10-16/electric-car-brand-byd-leads-race-to-make-cheap-evs-despite-tariffs">BYD Is Winning the Global Race to Make Cheaper EVs</a>

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

The Big Take from Bloomberg News brings you inside what’s shaping the world's economies with the smartest and most informed business reporters around the world. The context you need on the stories that can move markets. Every afternoon.

Big Take

We’re taking The Big Take to Asia. Each week, Bloomberg’s Oanh Ha tells a story from the home of the world's most dynamic economies - and the markets, tycoons and businesses that drive the ever-shifting region.

We’re taking The Big Take to Asia. Each week, Bloomberg’s Oanh Ha tells a story from the home of the world's most dynamic economies - and the markets, tycoons and businesses that drive the ever-shifting region.

Big Take Asia

How China’s BYD Became King of the Affordable EV

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/6ff3054c-82c8-4d17-b602-b211014bea44/transcript

When the Seattle Seahawks take on the New England Patriots on Sunday, more than $2.6 billion in wagers will be on the line. A growing share — $800 million — will come through prediction markets like Kalshi and Polymarket that are transforming how sports betting works in the US.

On today’s Big Take podcast, professional sports gambler Rufus Peabody discusses why he has shifted more of his betting to prediction markets. And markets reporter Justina Lee  and sports business reporter Ira Boudway sit down with host David Gura to discuss why these markets are drawing pros like Peabody — and the concerns the platforms raise for regulators and traditional sportsbooks.

Read more: Gambling Pros Adjust to a Super Bowl on the Prediction Markets

Hosted by David Gura; Produced by Julia Press; Reported by Justina Lee and Ira Boudway; Edited by Jeffrey Grocott.

Fact-checking by Eleanor Harrison-Dengate; Engineering by Katie McMurran.

Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

When the Seattle Seahawks take on the New England Patriots on Sunday, more than $2.6 billion in wagers will be on the line. A growing share &mdash; $800 million &mdash; will come through prediction markets like Kalshi and Polymarket that are transforming how sports betting works in the US.
On today&rsquo;s Big Take podcast, professional sports gambler Rufus Peabody discusses why he has shifted more of his betting to prediction markets. And markets reporter Justina Lee&nbsp; and sports business reporter Ira Boudway sit down with host David Gura to discuss why these markets are drawing pros like Peabody &mdash; and the concerns the platforms raise for regulators and traditional sportsbooks.
Read more:&nbsp;<a href="https://www.bloomberg.com/news/articles/2026-02-05/super-bowl-lx-is-bringing-professional-gamblers-to-prediction-markets?srnd=undefined">Gambling Pros Adjust to a Super Bowl on the Prediction Markets</a>
Hosted by David Gura; Produced by Julia Press; Reported by Justina Lee and Ira Boudway; Edited by Jeffrey Grocott.
Fact-checking by Eleanor Harrison-Dengate; Engineering by Katie McMurran.
Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

Betting on Sunday’s Game? Here’s Who You’re Up Against

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/9c99ab00-2581-45dd-9129-b3e9013cd74c/transcript

Shares of Novo Nordisk were down Thursday morning after Hims & Hers introduced a compounded version of its Wegovy pill. The dip came two days after Novo predicted its sales could drop as much as 13% this year as the company factors in competition from generic drugs that could crop up as its patents expire around the world.

On today’s Big Take podcast, Bloomberg reporters Naomi Kresge and Amber Tong talk to host David Gura about the year ahead for weight-loss drugs, from compounded products cutting into leading companies’ market share to generics that could upend the market globally.

Read more: Generic Ozempic Makers Are Coming to Upend the Obesity Market

Further listening: 
Welcome To Ozempictown, USA (No, It’s Not Hollywood)
Cheap Ozempic Copycats Are Everywhere. Are They Safe?

Hosted by David Gura; Produced by David Fox and Rachael Lewis-Krisky; Reported by Amber Tong and Naomi Kresge; Edited by Aaron Edwards.

Fact-checking by Eleanor Harrison-Dengate; Engineering by Alex Sugiura.

Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

Shares of Novo Nordisk were down Thursday morning after Hims &amp; Hers introduced a compounded version of its Wegovy pill. The dip came two days after Novo predicted its sales could drop as much as 13% this year as the company factors in competition from generic drugs that could crop up as its patents expire around the world.
On today&rsquo;s Big Take podcast, Bloomberg reporters Naomi Kresge and Amber Tong talk to host David Gura about the year ahead for weight-loss drugs, from compounded products cutting into leading companies&rsquo; market share to generics that could upend the market globally.
Read more: <a href="https://www.bloomberg.com/news/features/2026-01-14/novo-nordisk-braces-as-generic-weight-loss-drugs-come-to-upend-market">Generic Ozempic Makers Are Coming to Upend the Obesity Market</a>
Further listening:&nbsp;
<ul>
<li aria-level="1"><a href="https://www.bloomberg.com/news/articles/2024-08-07/ozempic-to-lose-weight-transforms-local-economy-in-kentucky">Welcome To Ozempictown, USA (No, It&rsquo;s Not Hollywood)</a></li>
<li aria-level="1"><a href="https://www.bloomberg.com/news/articles/2024-07-23/are-ozempic-wegovy-mounjaro-zepbound-knockoff-drugs-safe">Cheap Ozempic Copycats Are Everywhere. Are They Safe?</a></li>
</ul>
Hosted by David Gura; Produced by David Fox and Rachael Lewis-Krisky; Reported by Amber Tong and Naomi Kresge; Edited by Aaron Edwards.
Fact-checking by Eleanor Harrison-Dengate; Engineering by Alex Sugiura.
Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

Generic Versions of Weight Loss Drugs Will Upend the Market

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/368866a2-338c-451a-b8f8-b3e801383071/transcript

AI anxiety is coursing through the stock market right now. From Tuesday’s global selloff in software and technology stocks to last week’s $381 billion Microsoft rout, investors are skittish over any sign of an AI bubble.

On today’s Big Take podcast, Bloomberg Big Tech editor Sarah Frier joins host Sarah Holder to discuss the coming AI reckoning and why pressure is building on tech companies to prove all their AI investments will pay off big — and soon.  

Hosted by Sarah Holder; Produced by David Fox; Reported by Sarah Frier; Edited by Tracey Samuelson.

Fact-checking by Rachael Lewis-Krisky and Eleanor Harrison-Dengate; Engineering by Katie McMurran and Alex Sugiura.

Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

AI anxiety is coursing through the stock market right now. From Tuesday&rsquo;s global selloff in software and technology stocks to last week&rsquo;s $381 billion Microsoft rout, investors are skittish over any sign of an AI bubble.
On today&rsquo;s Big Take podcast, Bloomberg Big Tech editor Sarah Frier joins host Sarah Holder to discuss the coming AI reckoning and why pressure is building on tech companies to prove all their AI investments will pay off big &mdash; and soon. &nbsp;
Hosted by Sarah Holder; Produced by David Fox; Reported by Sarah Frier; Edited by Tracey Samuelson.
Fact-checking by Rachael Lewis-Krisky and Eleanor Harrison-Dengate; Engineering by Katie McMurran and Alex Sugiura.
Senior Producer: Naomi Shavin; Deputy Executive Producer: Julia Weaver. Executive Producer: Nicole Beemsterboer.

Has the AI Reckoning Arrived?

https://api.omny.fm/orgs/e73c998e-6e60-432f-8610-ae210140c5b1/clips/a528034b-2ab4-4da7-94a7-b3e7011fa21c/transcript

How China’s BYD Became King of the Affordable EV

In 2 playlist(s)

Big Take

Social links

Follow podcast

Recent clips